Astera Labs vs. Arm: Which Technology Stock Is a Better Buy for 2027?

The artificial intelligence boom has investors searching for the next high-growth engine, leading many to compare the explosive momentum of Astera Labs (NASDAQ:ALAB) with the established architectural dominance of Arm (NASDAQ:ARM).

Astera Labs provides the essential connectivity hardware that links AI chips together, while Arm designs the fundamental blueprints used by almost every mobile and data center processor today. While both companies are central to the hardware cycle, they offer very different risk and reward profiles for investors seeking exposure to AI infrastructure.

The case for Astera Labs

Astera Labs focuses on solving data bottlenecks in high-performance computing by selling purpose-built connectivity solutions for cloud and AI infrastructure. The company works closely with major hyperscalers and GPU vendors to ensure its hardware can handle the intense data demands of modern server racks. In its latest annual report, Astera Labs noted that one end customer accounted for over 70% of revenue, while the top three combined for roughly 86%. Customer concentration like this adds a layer of risk to the business.

In the 12 months ended Sept. 30, 2026, revenue reached nearly $1.6 billion, representing growth of approximately 115.2% compared to the prior twelve-month period. This rapid expansion highlights the intense demand for connectivity hardware as data centers upgrade their capabilities for machine learning workloads. The company reported net income of nearly $461.3 million during this period, indicating that the business can generate significant profits even while scaling rapidly.

As of its December 2025 balance sheet, the current ratio is nearly 10.2x, indicating the company's ability to cover its short-term liabilities with short-term assets. The debt-to-equity ratio is approximately 0.0x, indicating the company has no debt relative to its shareholders’ equity. In the fiscal year ended Dec. 31, 2025, free cash flow was nearly $281.8 million. Note that stock-based compensation accounted for roughly 50.1% of operating cash flow, inflating reported cash generation, since SBC is a non-cash expense added back in the cash flow statement.

The case for Arm

Arm operates a unique and highly profitable business model by licensing its compute architecture to the world's leading chipmakers. Rather than manufacturing physical chips, the company collects licensing fees and royalties every time a device containing its technology is sold. This strategy has allowed Arm to become a cornerstone of semiconductor stocks, serving diverse markets ranging from smartphones and PCs to autonomous vehicles and massive cloud data centers.

In the 12 months ended Sept. 30, 2026, revenue reached nearly $5.5 billion, marking an increase of roughly 23.8% over the previous year. This steady growth is driven by the increasing complexity of chips, which often leads to higher royalty rates per device. Net income for this time frame was approximately $936.0 million, supported by an operating margin benefiting from low overhead costs associated with software and intellectual property licensing.

As of its March 2026 balance sheet, the debt-to-equity ratio was approximately 0.1x, and the current ratio was nearly 6.0x. These figures indicate a conservative financial structure with plenty of liquidity to fund future research and development. In the fiscal year ended March 31, 2026, free cash flow reached nearly $979.0 million. Note that stock-based compensation accounted for roughly 69% of operating cash flow, inflating reported cash generation, since SBC is a non-cash expense added back in the cash flow statement.

Risk profile comparison

Astera Labs faces significant revenue concentration, with a small group of large customers accounting for the vast majority of its sales. The company must also navigate an intensely competitive market against established giants like Broadcom (NASDAQ:AVGO) and Marvell Technology (NASDAQ:MRVL), as well as smaller rivals like Credo Technology Group Holding (NASDAQ:CRDO). Additionally, its reliance on a limited number of manufacturing partners, such as TSMC, exposes the business to potential supply chain disruptions or geopolitical instability in East Asia.

Arm operates in a highly competitive environment where rivals may choose alternative instruction sets or develop proprietary designs to avoid royalty payments. While Arm dominates the mobile market, its expansion into the data center and automotive sectors requires constant innovation to stay ahead of specialized competitors. Furthermore, the company faces risks associated with global trade regulations, particularly regarding its ability to sell technology in certain international markets, which could limit its long-term growth opportunities. Rambus (NASDAQ:RMBS) serves as another example of a firm in the specialized IP space that faces similar licensing challenges.

Valuation comparison

Astera Labs looks more attractive on a relative basis, as it carries a lower Forward P/E and P/S ratio while delivering faster revenue growth.

Valuation metrics include those sourced from Financial Modeling Prep (FMP) and may differ from those of other data providers.

Which stock would I buy for 2027?

Astera Labs is the one I'd own for 2027 and beyond, because it looks like a company early in a very long runway. It started with a narrow obsession: clearing data bottlenecks in AI servers, and it has repeatedly shipped first-to-market products on the standards hyperscalers depend on. That focus earned trust with the biggest buyers in tech, and those relationships now pull Astera into each new generation of AI hardware. The culture reads as builders reinvesting to stay ahead: Astera has roughly doubled its engineering team while embedding its software into customers' systems, making its chips harder to swap out. Heavy equity compensation also gives employees a real stake in the outcome. Arm earns its reputation as the steadier toll collector across phones, PCs, cars, and data centers. Still, its story is largely about defending a dominant position, while Astera's is about building one. The risk is customer concentration, since a few large buyers drive Astera’s results, and a pause by any of them would sting. Investors who buy should think in years rather than quarters, expect some bumpy stretches, and judge the company by whether its customer base keeps broadening and its product lineup keeps expanding.

Seena Hassouna has positions in Astera Labs. The Motley Fool has positions in and recommends Arm Holdings, Broadcom, and Marvell Technology. The Motley Fool recommends Astera Labs. The Motley Fool has a disclosure policy.